These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1525043)

  • 21. [Effect of 24,25-dioxycholecalciferol on calcium-phosphorus metabolism and bone tissue in rats with experimental renal failure].
    Alekseeva IA
    Vopr Pitan; 1984; (3):55-8. PubMed ID: 6332422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procollagen type I C-terminal extension peptide in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Manni M; Pasquali M; Perruzza I; Sardella D; Spurio A
    Am J Nephrol; 1992; 12(4):246-51. PubMed ID: 1481872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Bianchi ML; Colantonio G; Campanini F; Rossi R; Valenti G; Ortolani S; Buccianti G
    Nephrol Dial Transplant; 1994; 9(11):1595-9. PubMed ID: 7870349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
    Massry SG; Goldstein DA; Malluche HH
    Kidney Int; 1980 Oct; 18(4):409-18. PubMed ID: 7014981
    [No Abstract]   [Full Text] [Related]  

  • 28. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats].
    Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA
    Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.
    Antoniazzi F; Radetti G; Zamboni G; Gambaro G; Adami S; Tatò L
    Bone Miner; 1993 May; 21(2):151-6. PubMed ID: 8358252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.
    Baker LR; Abrams L; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int; 1989 Feb; 35(2):661-9. PubMed ID: 2651758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism.
    Tsukamoto Y; Nomura M; Takahashi Y; Takagi Y; Yoshida A; Nagaoka T; Togashi K; Kikawada R; Marumo F
    Nephron; 1991; 57(1):23-8. PubMed ID: 2046811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the dihydroxylated metabolites of vitamin D and dietary phosphate restriction on bone disease in uraemic rats.
    Main J; Velasco N; Heyes SD; Whiting P; Fraser RA; Catto GR
    Clin Sci (Lond); 1986 Nov; 71(5):539-43. PubMed ID: 3490349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
    Colodro IH; Brickman AS; Coburn JW; Osborn TW; Norman AW
    Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS; Jones G
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Donato G; Massimetti C; Ballanti P; Bondatti F; Della Rocca C; Smacchi A; Mantazzoli F; Cinotti GA
    Adv Exp Med Biol; 1986; 208():297-303. PubMed ID: 3494388
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.